Development of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
$139,500Y01FY2020AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To facilitate the development of microbiome-based products, Fecal Microbiota Transplant (FMT) and Live Biotherapeutic Products (LBPs).
View original record on NIH RePORTER →